Suppliers / Zhejiang Kingland Pharmaceutical

Zhejiang Kingland Pharmaceutical

China Updated 9 July 2026

Zhejiang Kingland Pharmaceutical is an API manufacturer based in China. It holds 16 active US drug master files across a filed portfolio of 8 molecules.

16
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Alogliptin US FDA 2
Aniracetam US FDA 2
Biotin US FDA 2
Edaravone US FDA 2
Ferric Carboxymaltose US FDA 2
Folic Acid US FDA 2
Ornithine US FDA 2
Riociguat US FDA 2

Also appears on these molecule pages

Questions about Zhejiang Kingland Pharmaceutical

Does Zhejiang Kingland Pharmaceutical hold a US DMF or a CEP?
Zhejiang Kingland Pharmaceutical holds 16 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Zhejiang Kingland Pharmaceutical make?
8 molecules are on record against Zhejiang Kingland Pharmaceutical, including Alogliptin, Aniracetam, Biotin and Edaravone. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Kingland Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability